1. Home
  2. OPTN vs CRT Comparison

OPTN vs CRT Comparison

Compare OPTN & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • CRT
  • Stock Information
  • Founded
  • OPTN 2010
  • CRT 1991
  • Country
  • OPTN United States
  • CRT United States
  • Employees
  • OPTN N/A
  • CRT N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • CRT Oil & Gas Production
  • Sector
  • OPTN Health Care
  • CRT Energy
  • Exchange
  • OPTN Nasdaq
  • CRT Nasdaq
  • Market Cap
  • OPTN 55.4M
  • CRT 64.0M
  • IPO Year
  • OPTN 2017
  • CRT 1992
  • Fundamental
  • Price
  • OPTN $9.14
  • CRT $11.75
  • Analyst Decision
  • OPTN Hold
  • CRT
  • Analyst Count
  • OPTN 3
  • CRT 0
  • Target Price
  • OPTN $9.00
  • CRT N/A
  • AVG Volume (30 Days)
  • OPTN 166.1K
  • CRT 26.8K
  • Earning Date
  • OPTN 03-26-2025
  • CRT 01-01-0001
  • Dividend Yield
  • OPTN N/A
  • CRT 8.46%
  • EPS Growth
  • OPTN N/A
  • CRT N/A
  • EPS
  • OPTN N/A
  • CRT 1.13
  • Revenue
  • OPTN $78,226,000.00
  • CRT $7,711,133.00
  • Revenue This Year
  • OPTN $13.42
  • CRT N/A
  • Revenue Next Year
  • OPTN $38.54
  • CRT N/A
  • P/E Ratio
  • OPTN N/A
  • CRT $10.40
  • Revenue Growth
  • OPTN 10.20
  • CRT N/A
  • 52 Week Low
  • OPTN $4.82
  • CRT $8.88
  • 52 Week High
  • OPTN $22.50
  • CRT $14.98
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 81.15
  • CRT 65.21
  • Support Level
  • OPTN $9.12
  • CRT $11.60
  • Resistance Level
  • OPTN $9.35
  • CRT $12.43
  • Average True Range (ATR)
  • OPTN 0.25
  • CRT 0.34
  • MACD
  • OPTN 0.35
  • CRT 0.09
  • Stochastic Oscillator
  • OPTN 88.99
  • CRT 68.29

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: